142 related articles for article (PubMed ID: 16927186)
1. Mass transport properties of progesterone and estradiol in model microemulsion formulations.
Land LM; Li P; Bummer PM
Pharm Res; 2006 Oct; 23(10):2482-90. PubMed ID: 16927186
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an eucalyptus oil containing topical drug delivery system for selected steroid hormones.
Biruss B; Kählig H; Valenta C
Int J Pharm; 2007 Jan; 328(2):142-51. PubMed ID: 16950579
[TBL] [Abstract][Full Text] [Related]
3. Toward Developing Discriminating Dissolution Methods for Formulations Containing Nanoparticulates in Solution: The Impact of Particle Drift and Drug Activity in Solution.
Arce FA; Setiawan N; Campbell HR; Lu X; Nethercott MJ; Bummer P; Su Y; Marsac PJ
Mol Pharm; 2020 Nov; 17(11):4125-4140. PubMed ID: 32965123
[TBL] [Abstract][Full Text] [Related]
4. Formulation optimization of estradiol microemulsion using response surface methodology.
Tsai YH; Fu LT; Huang CT; Chang JS; Huang YB; Wu PC
J Pharm Sci; 2011 Oct; 100(10):4383-9. PubMed ID: 21544822
[TBL] [Abstract][Full Text] [Related]
5. Predicting skin penetration of actives from complex cosmetic formulations: an evaluation of inter formulation and inter active effects during formulation optimization for transdermal delivery.
Wiechers JW; Watkinson AC; Cross SE; Roberts MS
Int J Cosmet Sci; 2012 Dec; 34(6):525-35. PubMed ID: 22950455
[TBL] [Abstract][Full Text] [Related]
6. Microemulsion formulations for the transdermal delivery of testosterone.
Hathout RM; Woodman TJ; Mansour S; Mortada ND; Geneidi AS; Guy RH
Eur J Pharm Sci; 2010 Jun; 40(3):188-96. PubMed ID: 20304048
[TBL] [Abstract][Full Text] [Related]
7. Microemulsions for topical delivery of estradiol.
Peltola S; Saarinen-Savolainen P; Kiesvaara J; Suhonen TM; Urtti A
Int J Pharm; 2003 Mar; 254(2):99-107. PubMed ID: 12623186
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Aprotinin Loaded Microemulsion Formulations for Parenteral Drug Delivery: Preparation, Characterization, in vitro Release and Cytotoxicity Studies.
Okur NÜ; Özdemir Dİ; Kahyaoğlu ŞG; Şenyiğit ZA; Aşıkoğlu M; Genç L; Karasulu HY
Curr Drug Deliv; 2015; 12(6):668-79. PubMed ID: 26306401
[TBL] [Abstract][Full Text] [Related]
9. [Water in oil microemulsions containing NaCl for transdermal delivery of fluorouracil].
Xiao YY; Liu F; Chen ZP; Ping QN
Yao Xue Xue Bao; 2011 Jun; 46(6):720-6. PubMed ID: 21882535
[TBL] [Abstract][Full Text] [Related]
10. NMR characterisation and transdermal drug delivery potential of microemulsion systems.
Kreilgaard M; Pedersen EJ; Jaroszewski JW
J Control Release; 2000 Dec; 69(3):421-33. PubMed ID: 11102682
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies.
Kantarci G; Ozgüney I; Karasulu HY; Arzik S; Güneri T
AAPS PharmSciTech; 2007 Nov; 8(4):E91. PubMed ID: 18181551
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the incorporation of model steroids into non-ionic micellar and microemulsion systems.
Malcolmson C; Lawrence MJ
J Pharm Pharmacol; 1993 Feb; 45(2):141-3. PubMed ID: 8095531
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of suspoemulsions for in situ-forming polymeric microspheres and controlled release of progesterone.
Turino LN; Mariano RN; Mengatto LN; Luna JA
J Microencapsul; 2015; 32(6):538-46. PubMed ID: 26218541
[TBL] [Abstract][Full Text] [Related]
14. Influence of microemulsion-mucin interaction on the fate of microemulsions diffusing through pig gastric mucin solutions.
Zhang J; Lv Y; Wang B; Zhao S; Tan M; Lv G; Ma X
Mol Pharm; 2015 Mar; 12(3):695-705. PubMed ID: 25608210
[TBL] [Abstract][Full Text] [Related]
15. Formulation design of microemulsion for dermal delivery of penciclovir.
Zhu W; Yu A; Wang W; Dong R; Wu J; Zhai G
Int J Pharm; 2008 Aug; 360(1-2):184-90. PubMed ID: 18541394
[TBL] [Abstract][Full Text] [Related]
16. Study of isopropyl myristate microemulsion systems containing cyclodextrins to improve the solubility of 2 model hydrophobic drugs.
Nandi I; Bari M; Joshi H
AAPS PharmSciTech; 2003; 4(1):E10. PubMed ID: 12916919
[TBL] [Abstract][Full Text] [Related]
17. Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation.
Thakkar PJ; Madan P; Lin S
Pharm Dev Technol; 2014 May; 19(3):373-84. PubMed ID: 23634780
[TBL] [Abstract][Full Text] [Related]
18. Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effects of cosurfactants.
El Maghraby GM
Int J Pharm; 2008 May; 355(1-2):285-92. PubMed ID: 18243604
[TBL] [Abstract][Full Text] [Related]
19. The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations.
Miller JM; Beig A; Carr RA; Webster GK; Dahan A
Mol Pharm; 2012 Mar; 9(3):581-90. PubMed ID: 22280478
[TBL] [Abstract][Full Text] [Related]
20. Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia).
Ali J; Akhtar N; Sultana Y; Baboota S; Ahuja A
Methods Find Exp Clin Pharmacol; 2008 May; 30(4):277-85. PubMed ID: 18773122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
